A Study of SPY072 in Rheumatic Disease
Phase 2
285
about 2.6 years
18+
13 sites in AZ, CA, FL +2
What this study is about
This trial is testing a treatment called SPY072 compared to a placebo in adults with rheumatic diseases. The goal is to see if SPY072 is effective and safe for this condition.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take SPY002-072
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Axial Spondyloarthritis: Change from baseline in Ankylosing Spondylitis Disease Activity Score (ADAS), Rheumatoid Arthritis: Change from baseline in Disease Activity Score in 28 joints (c-reactive protein) (DAS-CRP)
Secondary: Psoriatic Arthritis: Change from baseline in Disease Activity Index for Psoriatic Arthritis (DAPSA)
Dermatology, Immune, Musculoskeletal